Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Biostage preclinical study results published in new report

Published 03/13/2018, 08:41 AM
© Reuters.  Biostage preclinical study results published in new report
  • Biostage (NASDAQ:BSTG) announces pre-clinical large-animal study results for its Cellspan esophageal implants.
  • The study, published in Nature Scientific Reports, demonstrated the feasible and reproducible use of the company's Cellframe technology to regenerate a functioning esophagus using a proprietary removable synthetic scaffold carrying autologous stem cells.
  • The study results indicate that scaffolds seeded with the patient's own mesenchymal stem cells may provide a safer alternative for some patients compared to the gastro-intestinal conduit technique used following resection of the esophagus.
  • Now read: Aralez Pharmaceuticals Inc. 2017 Q4 - Results - Earnings Call Slides


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.